Abstract
It is about 10 years since the identification of the first Mer line, A172 (Day and Ziolkowski, 1979), a human astrocytoma line produced by Giard, et al.(1973). To review, Mer lines are human cell lines defined by their relative inability to support the growth of adenovirus 5 that has been treated with N-methyl-N -nitro-N-nitrosoguanidine (MNNG) prior to infection of cell monolayers (Day, et al., 1980a,b). Such lines lack, without exception, the ability to repair m6 Gua produced in their DNA by certain methylating agents (Day, et al., 1980a; Day, et al., 1984), and are thus Mex- by the definition of Sklar and Strauss (1981). Mer- strains produced from human tumors are highly sensitive with respect to Mer+ cells as assessed by several endpoints to agents that react with the O6 of guanine: sister chromatid exchange (Day, et al., 1980a), mutation induction (Baker, et al., 1979, 1980, Domoradski, et al., 1984), cell killing by MNNG or nitrosoureas (Day, et al., 1980a,b; Erickson, 1980a,b; Scudiero, et al., 1984 a,b; Gibson, et al., 1986). The results obtained in cell culture are clear-cut; for example, with MNNG as the damaging agent, the inactivation slopes of survival curves of Mer- cells are up to 50 fold steeper than are those of Mer+ cells (Scudiero, et al., 1984a). Several groups have inserted parts or all of the E. coli ada gene into Mex- cells and have provided evidence that such differential sensitivity is likely due to differential repair of m6Gua (Brennand and Margison, 1986, Ishizaki, et al., 1986; Kataoka, et al., 1986; Samson, et al., 1986; Fox, et al., 1987), a point which has been discussed previously, and for which there is substantial evidence (Day, et al., 1987). No matter how persuading the cell culture evidence, there is little evidence to demonstrate that Mer- cells occur in tumors; i.e., that some fraction of human tumors is composed of Mer- cells.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aubin, R., Weinfeld, M., and Paterson, M.C., 1988, Factors influencing efficiency and reproducibility of polybreneassisted gene transfer. Somatic Cell and Mol. Genet., 14:155.
Ayres, K., Sklar, R., Larson, K., Lindgren, V., and Strauss, B., 1982, Regulation of the capacity for O6-methylguanine removal from DNA in human lymphoblastoid cells studied by cell hybridization. Mol. Cell. Biol., 2:904.
Baker, R.M., Van Voorhis, W.C., and Spencer, L.A., 1979, HeLa cell variants that differ in sensitivity to monofunctional alkylating agents, with independence of cytotoxic and mutagenic responses, Proc. Natl. Acad. Sci. USA, 76:5249.
Baker, R.M., Zuerndorfer, G., and Mandel, R., 1980, Enhanced susceptibility of a xeroderma pigmentosum cell line to mutagenesis by MNNG and EMS, Environ. Mutagenesis, 2:269.
Bigner, S.H., Mark, J., Burger, P.C., Mahaley, M.S., Jr., Bullard, D.E., Muhlbaier, L.H., and Bigner, D.D., 1988, Specific chromosomal abnormalities in malignant human gliomas. Cancer Res., 88:405.
Birchmeier, C., Sharma, S., and Wigler, M., 1987, Expression and rearrangement of the ROSI gene in human glioblastoma cells. Proc. Natl. Acad. Sci. USA, 84:9270.
Brennand, J., and Margison, G.P., 1986, Reduction of the toxicity and mutagenicity of alkylating agents in mammalian cells harboring the Escherichia coli alkyltransferase gene. Proc. Natl. Acad. Sci. USA, 83:6292.
Cook, A.W., Carter, W.A., Nidzgorski, R., and Akhtar, L., 1983, Human brain tumor-derived cell lines: growth rate reduced by human fibroblast interferon. Science, 219:881.
Day, R. S., III and Ziolkowski, C.H.J., 1979, Human brain tumour cell strains with deficient host-cell reactivation of N-methyl-N′-nitro-N-nitrosoguanidine-damaged adeno-virus 5, Nature, 279:797.
Day, R.S., III, Ziolkowski, C.H.J., Scudiero, D.A., Meyer, S. A., Mattern, M.R., 1980a, Human tumor cell strains defective in the repair of alkylation damage, Carcinogenesis, 1:21.
Day, R.S., III, Yarosh, D.B., and Ziolkowski, C.H.J., 1984, Relationship of methyl purines produced by MNNG in adenovirus 5 DNA to viral inactivation in repair-deficient (Mer-) human tumor cell strains. Mutation Res., 131: 45.
Day, R.S., III, Ziolkowski, C.H.J., Scudiero, D.A., Meyer, S. A., Lubiniecki, A.S., Girardi, A.J., Galloway, S.M., and Bynum, G.D., 1980b, Defective repair of alkylated DNA by human tumour and SV4 0-transformed human cell strains, Nature, 288:724.
Day, R.S., III, Babich, M.A., Yarosh, D.B., and Scudiero, D. A., 1987, The role of O6-methylguanine in human cell killing, sister-chromatid exchange induction and mutagenesis: a review. J. Cell. Sci. Suppl., 6:333.
Deinhardt, F., 1980, Biology of primate retroviruses, in: “Viral Oncology,” G. Klein, ed., Raven Press, New York, p. 357.
Diaz, M.O., Le Beau, M.M., Pitha, P., and Rowley, J.D., 1986, Interferon and c-ets-1 genes in the translocation (9;11)(p22;q23) in human acute monocytic leukemia, Science. 231:265.
Diaz, M.O., Zieman, S., Le Beau, M.M., Pitha, P., Smith, S. D., Chilcote, R., and Rowley, J.D., 1988, Homozygous deletion of the alpha-and beta-1-interferon genes in human leukemia and derived cell lines. Proc. Natl. Acad. Sci. USA, 85:5259.
Domoradzki, J., Pegg, A.E., Dolan, M.E., Maher, V.M., and McCormick, J.J., 1984, Correlation between O6-methylguan-ine-DNA-methyltransferase activity and resistance of human cells to the cytotoxic and mutagenic effect of N-methyl-N′-nitro-N-nitrosoguanidine, Carcinogenesis, 5: 1641.
Erickson, L.C., Laurent, G., Sharkey, N.A., and Kohn, K.W., 1980a, DNA cross-linking and monoadduct removal in nitrosourea-treated human tumour cells. Nature, 288:727.
Erickson, L.C., Bradley, M.O., Ducore, J.M., Ewig, R.A.G., and Kohn, K.W., 1980b, DNA crosslinking and cytotoxicity in normal and transformed human cells treated with an-titumor nitrosoureas. Proc. Natl. Acad. Sci. USA, 77:467.
Fox, M., Brennand, J., and Margison, G.P., 1987, Protection of Chinese hamster cells against the cytotoxic and mutagenic effects of alkylating agents by transfection of the Escherichia coli alkyltransferase gene and a truncated derivative. Mutagenesis, 2:491.
Freeman, A.E., and Hoffman, R.M., 1986, In vivo-like growth of human tumors in vitro. Proc. Natl. Acad. Sci. USA, 83: 2694.
Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, R., Kersey, J.H., Dosik, H., and Parks, W.P., 1973, In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors, J. Natl. Cancer Inst., 51:1417.
Gibson, N.W., Hartley, J.A., Strong, J.M., and Kohn, K.W., 1986,2-chloroethyl (methylsulfonyl)methanesulfonate(NSC-338947) a more selective DNA alkylating agent than the chloroethylnitrosoureas. Cancer Res., 46:553.
Haley, J., Whittle, N., Bennett, P., Kinchington, D., Ullrich, A., and Waterfield, M., 1987, The human EGF receptor gene: structure of the 110 kb locus and identification of sequences regulating its transcription. Oncoqene Res., 1:375.
Ishizaki, K., Tsujimura, T., Fujio, C., Yangpei, Z., Yawata, H., Nakabeppu, Y., Sekiguchi, M., and Ikenaga, M., 1986, Expression of the truncated E. coli O6-methylguanine methyltransferase gene in repair-deficient human cells and restoration of cellular resistance to alkylating agents. Mutation Res., 184:121.
Jakobovits, E.B., Majors, J.E., and Varmus, H.E., 1984, Hormonal regulation of the Rous sarcoma virus src gene via a heterologous promoter defines a threshold dose for cellular transcription. Cell, 38:757.
James, C.D., Carlbom, E., Dumanski, J.P., Hansen, M., Nordenskjold, M., Collins, V.P. and Cavenee, W.K., 1988, Clonal genomic alterations in glioma malignancy stages. Cancer Res., 48:5546.
Jones, N., and Shenk, T., 1979, Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell, 17:683.
Kataoka, H., Hall, J., and Karran, P., 1986, Complementation of sensitivity to alkylating agents in Escherichia coli and Chinese hamster cells by expression of a cloned bacterial repair gene. EMBO J., 5:3195.
Kinzler, K.W., Bigner, S.H., Bigner, D.D., Trent, J.M., Law, M.L., O’Brien, S.J., Wong, A.J., and Vogelstein, B., 1987, Identification of an amplified, highly expressed gene in a human glioma. Science, 236:70.
Libermann, T.A., Nusbaum, H.R., Razon, N., Kris, R., Lax, I., Soreq, H., Whittle, N., Waterfield, M.D., Ullrich, A., and Schlessinger, J., 1985, Amplification, enchanced expression, and possible rearrangement of EGF receptor gene in primary human tumors of glial origin. Nature, 313:144.
Mark, D.F., Lu, S.D., Creasey, A.A., Yamamoto, R., and Lin, L.S., 1984, Site-specific mutagenesis of the human fibroblast interferon gene. Proc. Natl. Acad. Sci. USA, 81:5662.
Mosmann, T.J., 1983, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immun. Methods, 65:55.
Nister, M., Libermann, T.A., Betsholtz, C., Petterson, M., Clesson-Welsh, L., Heldin, C.H., Schlessinger, J., and Westermark, B., 1988, Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant cell lines. Cancer Res., 48:3910.
Ponten, J., 1975, Neoplastic human glia cells in culture, in: “Human Tumor Cells in Vitro”, J. Fogh, ed., Plenum Press, New York, p 175.
Resnitzky, D., Yarden, A., Zipori, D., and Kimchi, A., 1986, Autocrine beta-related interferon controls c-myc suppression and growth arrest during hematopoietic cell differentiation. Cell, 46:31.
Samson, L., Derfler, B., and Waldstein, E.A., 1986, Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes. Proc. Natl. Acad. Sci. USA, 83: 5607.
Sariban, E., Kohn, K.W., Zlotogorski, C., Laurent, G., D’lncalci, M., Day, R.S., III, Smith, B.H., Kornblith, P.L., and Grickson, L.C., 1987, DNA cross-linking responses of human malignant glioma cell strains to chloroethylnitrosoureas, cisplatin, and diaz iquone. Cancer Res., 47:3988.
Scudiero, D.A., Meyer, S.A., Clatterbuck, B.E., Mattern, M. R., Ziolkowski, C.H.J., and Day, R.S., III, 1984a, Relationship of DNA repair phenotypes of human fibroblast and tumor strains to killing by N-methyl-N′-nitro-N-nitrosoguanidine, Cancer Research, 44:961.
Scudiero, D.A., Meyer, S.A., Clatterbuck, B.E., Mattern, M. R., Ziolkowski, C.H.J., and Day, R.S., III, 1984b, Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res., 44:2467.
Shows, T.B., Sakaguchi, A.Y., Naylor, S.L., Goeddel, D.V., and Lawn, R.M., 1982, Clustering of leucocyte and interferon genes on human chromosome 9. Science, 218:373.
Sklar, R., and Strauss, B., 1981, Removal of O6-methylguanine from DNA of normal and xeroderma pigmentosum-derived lymphoblastoid cell lines, Nature, 289:417.
Watatani, M., Ikenaga, M., Hatanaka, T., Kinuta, M., Takai, S., Mori, T. and Kondo, S., 1985, Analysis of N-methyl N′-nitro-N-nitrosoguanidine (MNNG)-induced DNA damage in tumor cells strains from Japanese patients and demonstration of MNNG hypersensitivity of Mer-xenografts in athymic nude mice. Carcinogenesis, 6:549.
Waterfield, M.D., Scrace, G.T., Whittle, N., Stroobant, P., Johnsson, A., Wasteson, A., Westermark, B., Heldin, C.H., Huang, J.S., and Deuel, T.F., 1983, Platelet-derived growth factor is structurally related to the putative transforming protein p28 sis of simian sarcoma virus. Nature, 304:35.
Wilson, C.B., 1976, Chemotherapy of brain tumors, in: “Advances in Neurology, Vol. 15, Neoplasia in the Central Nervous System,” R.A. Thompson and J.R. Green, eds., Raven Press, New York. p. 361.
Wong, A.J., Bigner, S.H., Bigner, D.D., Kinzler, K.W., Hamilton, S.R., and Vogelstein, B., 1987, Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc. Natl. Acad. Sci. U.S.A., 84:6899.
Yamazaki, H., Fukui, Y., Ueyama, Y., Tamaoki, N., Kawamoto, T., Taniguchi, S., and Shibuya, M., 1988, Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors. Mol. Cell. Biol., 8:1816.
Yarosh, D.B., Rice, M., Day, R.S., III, Foote, R.S., and Mitra, S., 1984a, O6-methylguanine-DNA methyltransferase in human cells. Mutat. Res., 131:27.
Yarosh, D.B., Scudiero, D.A., Ziolkowski, C.H.J., Rhim, J.S., and Day, R.S., III., 1984b, Hybrids between human tumor cells differing in repair of MNNG-produced DNA damage. Carcinogenesis, 5:627.
Yarosh, D.B., Scudiero, D.A., Yagi, T., and Day, R.S., III, 1985, Human tumor cell strains both unable to repair O6-methylguanine and hypersensitive to killing by human alpha and beta interferons. Carcinogenesis, 6:883.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Press, New York
About this chapter
Cite this chapter
Day, R.S. et al. (1989). The Mer Minus Phenotype, Patient Response to Nitrosoureas, and Protooncogene Activation in Human Glioblastomas. In: Lambert, M.W., Laval, J. (eds) DNA Repair Mechanisms and Their Biological Implications in Mammalian Cells. NATO ASI Series, vol 182. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1327-4_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1327-4_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1329-8
Online ISBN: 978-1-4684-1327-4
eBook Packages: Springer Book Archive